18th Aug 2014 11:19
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 19 FEBRUARY 2014 TO: 18 AUGUST 2014
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
122,100 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
88,763 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
155,950 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
200,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
200,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
122,613 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
236,527,705 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 19 FEBRUARY 2013 TO: 18 AUGUST 2014
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
192,887 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
573,500 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
119,387 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
500,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
800,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
236,527,705 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME
3. PERIOD OF RETURN:
FROM: 19 FEBRUARY 2013 TO: 18 AUGUST 2014
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
204,700 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
124,300 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
249,050 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003
300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008
400,000 ORDINARY SHARES OF 0.1P EACH ON 18 JANUARY 2010
400,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
300,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011
168,650 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
236,527,705 ORDINARY SHARES OF 0.1P EACH
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS LONG TERM INCENTIVE PLAN 2008
3. PERIOD OF RETURN:
FROM: 19 FEBRUARY 2013 TO: 18 AUGUST 2014
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
561,817 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
47,366 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
1,014,451 ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
600,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011
300,000 ORDINARY SHARES OF 0.1P EACH ON 29 NOVEMBER 2013
500,000 ORDINARY SHARES OF 0.1P EACH ON 9 JUNE 2014
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
236,527,705 ORDINARY SHARES OF 0.1P EACH
For further information, please contact:
Adam George, Company Secretary, GW Pharmaceuticals plc
Telephone: +44 (0)1980 557000
James Steel / Oliver Jackson, Nominated Adviser, Peel Hunt LLP
Telephone: +44 (0)20 7418 8900
Related Shares:
GWP.L